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Background: To establish appropriate measures that deal with incidental findings (IFs), the neuroscience
community needs to address various ethical issues. The current state of research facilities regarding IFs and
investigator attitudes as well as potentially eligible research participants must be assessed prior to future discussions
and before the development of policies and guidelines. To this end, we conducted two questionnaire surveys to
clarify i) how IFs are addressed at neuroimaging research facilities in Japan and ii) the views of investigators and
potential research participants regarding the handling of IFs.
Methods: Thirty-one principal investigators (PIs) involved in the Strategic Research Program for Brain Sciences
(SRPBS), a government-funded project, were asked to fill out a questionnaire regarding ways IFs were handled at
the facility. A total of 110 investigators engaged in SRPBS tasks, including 31 PIs who participated in the research
facility survey and researchers conducting studies under the management of the PIs, and 500 individuals from the
general public (i.e., general population) were asked to select the most appropriate way to deal with IFs in two
scenarios, namely the medical school and humanities and social sciences department scenarios.
Results: More than 40% of PIs responded that they did not know or were unsure of what type of approach was
employed to handle IFs at their research facilities. Nevertheless, they were willing to improve the current status if
sufficient resources were provided. With regard to specialist involvement, 37.7% of investigators responded that it
was appropriate to have a specialist check all images in the medical school scenario, whereas 13.3% responded that
such involvement was appropriate in the humanities and social sciences department scenario. In contrast, 76.1%
and 61.0% of the general population indicated that specialist involvement was appropriate in the medical school
and humanities and social sciences department scenarios, respectively. These results show that expectations of the
general population exceed those of investigators regarding measures to address IFs. Both investigators and the
general population demanded more responsibility from PIs at medical institutions, compared to PIs at non-medical
institutions.
Conclusions: Based on our preliminary results, we recommended that a licensed physician perform a screening
test to appropriately examine clear abnormalities. These recommendations were implemented by the SRPBS as
guidelines for handling IFs in national research projects in Japan.
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An incidental finding (IF) is defined as “a finding concern-
ing an individual research participant that has potential
health or reproductive importance and is discovered in the
course of conducting research but is beyond the aims of the
study” [1]. In neuroimaging research, IFs include brain
tumors, cerebral aneurysms, or asymptomatic vascular
lesions, which are not directly related to research aims but
are found by magnetic resonance imaging (MRI) or
research MRI sequences. One study reported that the fre-
quency of brain-related IFs that are found by MRI or func-
tional magnetic resonance imaging (fMRI) studies is 13%
to 84% [1]. In that study, 1.2% of findings required imme-
diate referral for clinical evaluation, whereas 13% to 40.4%
of findings did not [1]. Recently, the neuroscience research
community has aimed to establish measures to handle
such findings, as various ethical questions regarding IFs
have been raised [2].
Research MRI images typically have lower resolution
and contrast [3], and are often unsuitable for clinical
diagnoses. Moreover, opportunities for non-physician in-
vestigators who are untrained in image evaluation to
conduct neuroimaging research in non-medical areas
(e.g., cognitive psychology and behavioral economics)
have increased. This can lead to an increased risk of
false-negative errors (i.e., a disease is overlooked) and
false-positive errors (i.e., a disease is inaccurately diag-
nosed). False-negative errors can lead a participant to
ignore the early symptoms of a disease and thereby ag-
gravate his or her condition. In fact, the majority of
healthy adults who participate in neuroimaging studies
expect the study to discover any abnormality that exists
[4]. In contrast, false-positive errors might significantly
burden participants (i.e., mentally, economically, and
temporally) until the absence of disease is confirmed. In-
deed, one study revealed that subsequent examination
confirmed all detected IFs to be false positives [5].
There is a general consensus within the research com-
munity that IFs should be addressed appropriately [6,7].
However, there exists evidence that IFs are handled differ-
ently across research facilities. According to a survey con-
ducted by Lawrenz and Sobotka, informed consent forms
that mentioned IFs were used in approximately 9%, 25%,
11%, and 37% of cases at federal institutions, relevant con-
ferences, universities, and other facilities, respectively, and
the contents differed for each form [8]. An Internet survey
conducted by Illes et al. showed that more than 80% of in-
vestigators encountered IFs during their studies; however,
only half of these investigators indicated that a standard
procedure existed for addressing IFs at their research facil-
ities [9]. With respect to specialist (neuroradiologist) in-
volvement, their responses ranged from “checks all
images” and “checks only equivocal findings” to “checks
no images at all” [9].Opinions regarding appropriate measures to be taken
by principal investigators (PIs) are also divided. Royal
and Peterson are against specialist involvement, as they
believe such involvement may increase the risk of false-
positive errors. In other words, a specialist, who is
concerned “about medicolegal liability from failing to
identify a serious IF,” may “err on the ‘safe side’ by
recommending further consultation” [10]. According to
Richardson, actively searching for abnormal findings vi-
olates participant privacy, although the PI is responsible
for providing “ancillary care” for a disease discovered
during a study [11]. Another view suggests that the
reading of all images or use of clinical scans by special-
ists is not always required [2,12]. In contrast, Milstein
asserts that the PI should provide the highest level of
care (e.g., detailed examinations and the use of clinical
devices), because otherwise, s/he may be sued if a dis-
ease worsens or the participant develops a disorder dur-
ing the course of research [13].
Given that various approaches are adopted by research
facilities with differing opinions among scholars, the rec-
ommendations summarized during the Detection and
Disclosure of Incidental Findings in Neuroimaging Re-
search workshop, which was held in 2005 by the National
Institutes of Health (NIH) and Stanford University, repre-
sented a significant breakthrough [14]. Five options were
provided for addressing IFs so that investigators can im-
plement the most appropriate option for them. In 2008,
Wolf et al. provided more detailed recommendations
regarding the ethical and legal aspects of IFs in neuroim-
aging and genetic/genomic research [1]. Furthermore, in
October 2012, the NIH and a working group supported
by US and Canadian government agencies discussed
measures to address IFs in neuroimaging research, and
published the results online [15,16]. However, directly
adopting these recommendations in countries other than
the US and Canada would require careful consideration.
In Japan, the Ministry of Education, Culture, Sports,
Science, and Technology (MEXT) launched the Strategic
Research Program for Brain Sciences (SRPBS) in 2008 to
strategically advance neuroscience research [17]. Gov-
ernment research conducted with public funds includes
many neuroimaging studies that use MRI and fMRI
techniques. However, the only guidance available regard-
ing IFs in neuroimaging research is found in the Guide-
lines on Ethical Issues of Noninvasive Research on
Human Brain Function, which was revised in 2009 by
the Japanese Neuroscience Society [18]. These guidelines
deem it appropriate to consult a specialist prior to dis-
closing an IF to a participant, but the reasons for this
approach are not mentioned. Moreover, these guidelines
only have binding power on association members. In
general, there has been little discussion regarding how
IFs should be addressed in Japan [19,20].
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policies or guidelines, we must first assess the current state
of relevant research facilities, and clarify attitudes of investi-
gators and potentially eligible research participants regard-
ing IFs. However, few empirical studies have investigated
the actual procedures for addressing IFs at research facil-
ities in Japan [19,20]. Moreover, the focus has been placed
on conducting surveys of investigators in most inter-
national studies [9,21], or of participants who have already
taken part in research [4,22,23], and few studies have inves-
tigated the attitudes of potential research participants
regarding IFs procedures. Thus, whether their attitudes dif-
fer from those of investigators is unclear. Therefore, the
present study used two questionnaires to survey the follow-
ing: i) how IFs are addressed at neuroimaging research fa-
cilities in Japan, and ii) the views of investigators and
potential research participants regarding the handling of
IFs. As issues surrounding IFs are still somewhat unex-
plored in Japan, we used a modified version of the five op-
tions established by Illes et al. [14], along with two





PIs of 31 research facilities involved in the SRPBS be-
tween 2008 and 2010 were recruited for this survey.
These research facilities were engaged in one of the fol-
lowing tasks: “Development of brain-machine inter-
faces,” “Development of highly original animal models,”
and “Development of technologies to measure and assist
brain mechanisms that support social behaviors.” The
questionnaires were mailed according to the address of
each research facility and the names of corresponding
PIs listed on the SRPBS website [17].
Investigators/general population survey
Study participants were a total of 110 investigators en-
gaged in SRPBS tasks, including 31 PIs who participated
in the research facility survey and researchers conduct-
ing studies under the management of the PIs. A list of
their addresses and names was obtained, and the ques-
tionnaires mailed, upon approval of the SRPBS. The
general population in this survey refers to registered
members of the Japan Management Association Research
Institute, which recruits volunteers who participate in
various studies [24]. A questionnaire was uploaded onto
the institute’s website, and registered volunteers were able
to choose whether or not to answer the questionnaire.
The questionnaire remained available until 500 responses
were received. We collected 100 from each age group ran-
ging from 20 to 60 years (250 from each gender) to avoid
sampling biases.Questionnaires
Between October and November 2010, the PIs, investiga-
tors, and the general population were asked to complete
an anonymous self-administered questionnaire. IFs were
defined as follows:
“‘Incidental findings (IFs)’ refer to unexpected health
problems (e.g., brain tumors, cerebral aneurysms, or
asymptomatic vascular disorders) discovered by
coincidence during a study on a research participant’s
MRI and/or fMRI brain images. The frequency of IFs
has been reported to be 13–84%, and 1.2% of IFs
require immediate examination. Study participants
benefit from these IFs because they are made aware of
their disease.However, imaging devices used for research purposes
may result in false-negative (i.e., judged healthy des-
pite having a disease) or false-positive (i.e., judged to
have a disease despite being healthy) errors. In false-
positive cases, participants may experience unneces-
sary stress and economic burden until the absence of
disease is confirmed.”
The survey respondents were also informed that MRI
is an examination method that uses a computer to ren-
der images of cross-sections of the body and that fMRI
visualizes brain activity using MRI. It took about 5 to
10 min to complete the questionnaires. Only the general
population received a reward in the form of points (ap-
proximately 20 to 30 points, which are exchangeable for
money at a rate of 1 yen/point) from the research firm.
This system is widely implemented by research firms in
Japan.
Research facility survey
In the questionnaire, we asked PIs i) questions regarding
basic characteristics, ii) how IFs are addressed at the re-
search facility (“At the research institution to which you
belong, which of options 1–6 (Table 1) is currently
employed as a means of addressing IFs?”), and iii) what
would be the appropriate way to address IFs if sufficient
resources were available (“If the research institution to
which you belong had adequate resources (e.g., personnel,
equipment, and research funds) to address IFs, which of
options 1–6 do you think would be most appropriate in
terms of the extent of the response?”). These six options
were obtained by reorganizing the five options established
by Illes et al. [14] to facilitate statistical analyses.
Investigators/general population survey
The questionnaire included i) basic characteristic ques-
tions, ii) a scenario of an abundantly funded neuroimaging
research study of patients at a medical school, which was
Table 1 Six options for addressing incidental
findings (IFs)
Option 1 When obtaining informed consent (IC), the
possibility of IFs is not explained at all to the participant.
Option 2 When obtaining IC, the participant is informed that “IFs
may be discovered, but will not be explained even if
they are found.”
Option 3 When obtaining IC, the participant is informed that “IFs
may be discovered, and if the principal investigator (PI)
considers them suspect, s/he will notify the participant.
However, a specialist (radiologist) does not check the
images.”
Option 4 When obtaining IC, the participant is informed that “if IFs
are suspected, a specialist (radiologist) will be asked to
check the images. If a genuine problem appears to exist,
the PI will notify the participant.” The cost for specialist
consultation is obtained from the PI’s research funds.
Option 5 When obtaining IC, the participant is informed that “a
specialist (radiologist) will check all images to discover
IFs. If a genuine problem appears to exist, the PI will
notify the participant.” The cost for specialist consultation
is obtained from the PI’s research funds.
Option 6 When obtaining IC, the participant is informed that “a
clinical device with more precision than that used for
research will be initially used to detect IFs. A specialist
(radiologist) will check all images, and the PI will notify
the participant when a firm diagnosis is established.” The
costs for the device and specialist consultation are
obtained from the PI’s research funds.
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school scenario), and iii) a scenario of a poorly funded
neuroimaging research study of healthy individuals in a
humanities or social sciences department, which was con-
ducted by a PI without a physician’s license (Humanities
and social sciences department scenario). We employed
these two scenarios based on a previous study showing
that attitudes of research participants toward IFs vary de-
pending on whether the research context is medical or
non-medical [4]. For ii) and iii), we asked all respondents
to select the most appropriate way to address IFs from the
six options. In addition, following Kirschen et al. [4], we
asked the general population about their iv) expectations
regarding image assessment in neuroimaging research.
Medical school scenario
A PI who is employed at a medical school-affiliated uni-
versity hospital is planning a study to clarify the relation-
ship between a person’s emotions and neural activity. Fifty
patients commuting to the affiliated hospital (who are at
least 20 years old) are recruited as participants. To meas-
ure neural activity, the plan is to use an fMRI device that
has a lower precision than does a device that would be
used in the clinical context. The PI is a licensed physician
who has previously conducted numerous studies using
fMRI devices. The allowable expenditure for this study is
10 million yen per year. What approach should the PI
adopt to address IFs?Humanities and social sciences department scenario
A PI who is employed at a humanities and social sci-
ences department of a university is planning a study to
clarify the relationship between a person’s emotions and
neural activity. Fifty healthy students from the university
(who are at least 20 years old) are recruited as partici-
pants. To measure neural activity, the plan is to use an
fMRI device that has a lower precision than does a de-
vice that would be used in the clinical context. Although
not a licensed physician, the PI has previously conducted
numerous studies using fMRI devices. The allowable ex-
penditure for this study is 1 million yen per year. What
approach should the PI adopt to address IFs?
Statistical analyses
We performed Wilcoxon rank sum and signed rank sum
tests using SAS version 9.1. To test for significance, we
used a two-tailed test with a criterion level of 5%.
Ethical considerations
This study was approved by the Ethics Committee of the




We mailed questionnaires to 31 PIs and obtained re-
sponses from 23 (response rate, 74.1%; Table 2). Of the 14
PIs who were conducting human research using imaging
devices at their research facilities, 6 (42.9%) reported prior
experience with IFs. These findings included brain tumors,
cerebrovascular disorders, cerebral aneurysms, arachnoid
cysts, and sinusitis. Figure 1 shows the current and ideal
approaches for handling IFs according to the answers pro-
vided by the 14 PIs. Six (42.9%) answered that they were
unsure of whether institutional guidelines exist, and 5
(35.7%) selected option 3 (Table 1) as the current institu-
tional policy. However, half of the PIs indicated that spe-
cialist involvement would be appropriate (option 4 or
higher) if resources were available. None of them currently
adopted option 1 or option 2, or considered these options
ideal. A comparison of responses concerning the current
approach and those concerning the ideal approach using
the Wilcoxon signed rank sum test revealed a significant
difference (P =0.0156).
Investigators/general population survey
Of the 110 investigators to whom questionnaires were
mailed, 70 responded (response rate, 63.6%; Table 2). Of
the 33 investigators who were conducting human re-
search, 10 (30.3%) reported having experience with IFs.
These findings included brain tumors, normal pressure
hydrocephalus, lacunar infarctions, venous malformations,
cavernous hemangiomas, cerebral aneurysms, arachnoid







Sex Male 22 (95.7) 65 (94.2) 250 (50.0)
Female 1 (4.4) 4 (5.8) 250 (50.0)
Age range (years) 20–29 0 (0) 0 (0) 100 (20.0)
30–39 2 (8.7) 14 (20.3) 100 (20.0)
40–49 10 (43.5) 25 (36.2) 100 (20.0)
50–59 8 (34.8) 25 (36.2) 100 (20.0)
>59 3 (13.0) 5 (7.3) 100 (20.0)
Affiliation University medical school 10 (43.5) 31 (45.6)
University science and engineering department 2 (8.7) 10 (14.7)
University humanities and social sciences department 1 (4.4) 2 (2.9)
Non-university research institution 4 (17.4) 13 (19.1)
Company 3 (13.0) 4 (5.9)
Other 3 (13.0) 8 (11.8)
Licensed physician Yes 10 (43.5) 35 (50.7)
No 13 (56.5) 34 (49.3)
Use of neuroimaging devices Yes 16 (69.6) 26 (37.7)
No 7 (30.4) 43 (62.3)
Research subjects Non-human 8 (34.8) 34 (50.0)c
Human 15 (65.2) 34 (50.0)c
w/ patients 12 (80.0) 25 (75.8)d
w/o patients 3 (20.0) 8 (24.2)d
w/ IF experience 6 (42.9)a 10 (30.3)d
w/o IF experience 8 (57.1)a 23 (69.7)d
Guidelines on IFs available Yes 4 (18.2) 8 (11.6)
No 12 (54.6) 27 (39.1)
Unsure 6 (27.3) 34 (49.3)






















Table 2 Basic characteristics (Continued)
Experience participating in studies that use neuroimaging technology Yes 8 (1.6)
w/ IF experience 2 (25.0)
w/o IF experience 6 (75.0)
No 492 (98.4)
aOf the 15 PIs who were conducting research on humans, one did not respond and was thus excluded from the calculations.
bOf the 70 investigators, one with incomplete information was excluded from the calculations.
cOf the 69 investigators with complete information, one without responses was excluded from the calculations.



































Opt 1. Not explained
Opt 2. Explained but not
disclosed
Opt 3. Disclosed w/o
specialist consultation
Opt 4. Consulted by
specialist if equivocal
Opt 5. Always consulted
by specialist
Opt 6. Clinical device
used
Figure 1 Comparison of actual and ideal treatments of incidental findings. Calculations were based on data obtained from the 14 principal
investigators who conduct human research using imaging devices.
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500 individuals from the general population who an-
swered the web-based questionnaire, 8 (1.6%) had prior
experience participating in research using neuroimaging
technology. Of these, 2 were found to have central ner-
vous system vasculitis and cerebral infarction during the
course of study participation.
Medical school scenario
More than 97% (67/69) of investigators considered it ap-
propriate to notify the participant if IFs were discovered
(option 3 or higher; Figure 2). However, 62.3% (43/69) of
investigators considered it unnecessary to have a special-
ist check the images (option 3 or lower), whereas 37.7%
indicated that having a specialist check the images was










Figure 2 Appropriate approaches that principal investigators should
investigators, one without complete information was excluded from the caof investigators responded that it was desirable to have a
specialist check all images (option 5 or higher), and none
supported the use of more precise clinical devices for
the purpose of detecting IFs (option 6). The Wilcoxon
rank sum test revealed that the responses did not differ
significantly according to whether an investigator was a
licensed physician, was affiliated with a medical school,
had used imaging equipment, had conducted human re-
search, or had guidelines for addressing IFs.
In contrast, only 23.8% (119/500) of the general popula-
tion considered it unnecessary to have a specialist check
the images (option 3 or lower), whereas 76.1% (381/500)
indicated that having a specialist check the images (option
4 or higher) was desirable. The proportion of individuals
who responded that it was desirable to have a specialist





Opt 1. Not explained
Opt 2. Explained but not
disclosed
Opt 3. Disclosed w/o
specialist consultation
Opt 4. Consulted by
specialist if equivocal
Opt 5. Always consulted by
specialist
Opt 6. Clinical device used
adopt according to the medical school scenario. *Of the 70
lculations.
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(option 6) was 17.8% (89/500). A significant difference
was detected (P <0.0001; Wilcoxon rank sum test) in re-
sponses between investigators and the general population.
Humanities and social sciences department scenario
Approximately 75% (50/68) of investigators considered it
important to notify the participant if IFs were discovered
(option 3 or higher; Figure 3). However, 86.8% (59/68) of
investigators considered it unnecessary to consult a spe-
cialist (option 3 or lower). Only 13.3% (9/68) of investiga-
tors indicated that a specialist should check the images
(option 4 or higher), and none supported the use of clin-
ical devices (option 6). The Wilcoxon rank sum test re-
vealed that responses did not differ significantly according
to whether an investigator was a licensed physician, was
affiliated with a medical school, had used imaging equip-
ment, had conducted human research, or had guidelines
for handling IFs.
Among the general population, 39.0% (195/500) con-
sidered specialist consultation unnecessary (option 3 or
lower), whereas 61.0% (305/500) responded that it was
desirable (option 4 or higher). Of these, approximately
half (31.6%) indicated that a specialist should check all
images (option 5 or higher), and 15% (75/500) supported
the use of clinical devices (option 6). A significant differ-
ence was detected (P <0.0001; Wilcoxon rank sum test)
in responses between investigators and the general
population.
Comparison of the medical school and humanities and
social sciences department scenarios
A significant difference (P <0.0001; Wilcoxon signed rank
sum test) was observed when investigator responses were











Figure 3 Appropriate approaches that principal investigators should
department scenario. *Of the 70 investigators, two without complete infoand social sciences department scenarios. Similarly, a sig-
nificant difference was observed in responses among the
general population (P <0.0001).
General population’s view on handling IFs
In response to the question, “How do you think investi-
gators verify whether a participant has an abnormality
during a research study using MRI or fMRI,” 80.8%
(404/500) of the general population indicated that they
expected specialist involvement (Table 3).
Discussion
This study is the first to assess the procedures for ad-
dressing IFs in neuroscience research facilities in Japan.
Unlike previous studies [4,9,21-23], we compared the
views of investigators and the general population re-
garding the handling of IFs. Moreover, the policy re-
garding IFs was implemented by the SRPBS, which took
into consideration the preliminary results of this study.
Current state of neuroimaging research facilities
Of the 14 research facilities that conduct neuroimaging
research on humans, 40% had previously encountered
IFs. Nonetheless, more than 40% of PIs indicated that
they did not know or were unsure of what type of ap-
proach was employed at their facilities. This finding is
consistent with previous reports on research facilities in
many other countries, and not unique to Japanese facil-
ities. A previous study found that 82% of investigators
reporting MRI-related studies had experienced IFs dur-
ing their studies; only 53% indicated that there was a
standardized facility procedure to address such discover-
ies [9]. In a survey of investigators from a leading Can-
adian neuroimaging center, the investigators emphasized11.8
16.6 15.0
80% 100%
Opt 1. Not explained
Opt 2. Explained but not
disclosed
Opt 3. Disclosed w/o
specialist consultation
Opt 4. Consulted by
specialist if equivocal
Opt 5. Always consulted by
specialist
Opt 6. Clinical device used
1.5
adopt according to the humanities and social sciences
rmation were excluded from the calculations.
Table 3 Expectations of the general population toward
image evaluation in neuroimaging research (n =500)
Modes of evaluation n (%)
No one checks the images 41 (8.2)
PI checks the images 55 (11.0)
Specialist checks the images only when there is a
suspected finding
294 (58.8)
Specialist checks all images 90 (18.0)
Specialist uses a clinical device to check all images 20 (4.0)
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address IFs [21].
In the present study, more than 90% of PIs indicated
that option 3 or higher was desirable if sufficient resources
were available, suggesting that the majority of PIs consid-
ered it appropriate to provide explanations of IFs to par-
ticipants in advance and to notify them when such
findings are discovered. Moreover, the gap between the ac-
tual and ideal approaches to IFs implied that PIs were will-
ing to improve the handling of IFs, as long as sufficient
resources are provided. When the government funds these
facilities, they should subsidize the expenses required to
establish policies and guidelines regarding IFs and to re-
cruit specialists for image evaluation to improve IF-related
efforts.
Preferences regarding specialist involvement
Views of investigators and the general population regard-
ing specialist involvement differed considerably. The pro-
portion of investigators who indicated that specialist
involvement was desirable (option 4 or higher) was 37.7%
in the medical school scenario and 13.3% in the human-
ities and social sciences department scenario. In contrast,
76.1% and 61.0% of the general population indicated that
specialist involvement was desirable in the medical school
and humanities and social sciences department scenarios,
respectively (option 4 or higher). This discrepancy likely
reflects the different views of PIs and the general popula-
tion regarding the current state of research facilities. The
PIs who responded to the questionnaire were already
aware that specialists are not always involved in neuroim-
aging research on humans (Figure 1). In contrast, 80% of
the general population expected specialists to check the
images in research facilities (Table 3).
Illes and Chin stated that participants may suffer harm
if no clinical evaluation is performed when there is a
finding that urgently requires further examination [2].
Therefore, they concluded that it would be appropriate
to entrust the image readings to a trained specialist [2].
Mamourian also supports this conclusion based on his
personal experience after finding a cerebral aneurysm on
his images during volunteer work in an MRI study [25].
Based on our findings, we can speculate that the generalpopulation expects specialist involvement as a means to
avoid false-negative errors. However, Royal and Peterson
believe that specialists are more likely to recommend
more detailed examinations because they fear liability,
causing mental, economical, and temporal burdens on
participants with false-positive errors [10]. One potential
reason for the difference in opinions reported across the
literature is that there are insufficient data to determine
how the involvement of a specialist would impact the
risk of false-negative and false-positive errors or the par-
ticipants’ welfare. A challenge for future studies will be
to empirically determine detection rates of IFs for spe-
cialists and PIs and compare them with subsequently
confirmed disease incidence rates.
Reactive responses vs. proactive responses
Almost all investigators who indicated that specialist in-
volvement was appropriate (option 4 or higher) considered
a “reactive” response adequate, only when there was a sus-
picious finding (option 4). On the other hand, more than
half of the general population considered a “proactive” [26]
response appropriate, which involves a specialist routinely
checking images and actively searching for IFs (option 5 or
higher). Furthermore, half of the general population sup-
ported a “very proactive” [26] response, i.e., taking images
with a clinical device that are not intended for research (op-
tion 6). In contrast, none of the investigators chose this
option.
At first glance, “proactive” and “very proactive” re-
sponse models seem superior to a “reactive” response
model in terms of the ability to reduce disease oversight
(i.e., risk of false-negative errors) by increasing the detec-
tion rate of abnormal findings. This approach is taken by
a number of research facilities, including the NIH
[3,25,27-29]. In addition, if a specialist joins a research
team in advance and immediately checks all images, s/he
could address any situations that require immediate or
emergency follow-up [30], which, in turn, will benefit
the participant.
However, it is an act that goes beyond formal research
objectives to provide a benefit to participants. Therefore, a
number of experts question the appropriateness of
attempting to reduce the risk of false-negative errors
[11,12]. In their view, the search for health problems that
would ordinarily be overlooked deviates from research ob-
jectives and is closer to medical practice [11,12,31]. Even if
such practices are regarded as responsibilities of a phys-
ician within a clinical setting, it is difficult to regard them
as fundamental responsibilities of the PI [12]. Some be-
lieve that results counterbalancing the detection rate for
clinically important IFs, believed to be 2% to 8% [14], are
unrealistic to expect, and attempts to implement these
models are impractical in light of the enormous effort and
expenditure required [3,14,30,32,33]. Our results, which
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“very proactive” models, are consistent with the aforemen-
tioned views toward PIs’ responsibilities and model
feasibility.
We found that the general population tends to support
measures that reflect expectations that exceed those of in-
vestigators (e.g., the introduction of therapeutic elements
into research), suggesting the presence of a “therapeutic
misconception” among the general population regarding re-
search. In other words, the general public may erroneously
expect therapeutic benefits from participating in a research
study [34,35]. Consent to participate in a study based on
misunderstandings such as expectation of benefits or
underestimation of risk does not represent true informed
consent [1,7,11,12,26,36]. As previously demonstrated by a
number of neuroimaging studies [4,22,23], the present
study findings also indicate the tendency of the general
public to expect practices similar to medical examinations;
in this regard, no distinction is made between research and
medical practice. A more detailed interview study targeting
the general public and research participants will be required
to confirm this finding.
PI responsibilities under various conditions
Both investigators and the general population supported a
more rigorous response in the medical school scenario
than in the humanities and social sciences department
scenario. Approximately 40% of investigators indicated
that specialist involvement would be appropriate (option 4
or higher) in the medical school scenario, as opposed to
approximately 13% in the humanities and social sciences
department scenario. In contrast, responses that included
“no explanation of IFs” (option 1) and “no notification
even if IFs were found” (option 2) increased 9-fold in the
humanities and social sciences department scenario from
2.9% in the medical school scenario. These findings were
unrelated to investigator background. Interestingly, a simi-
lar trend was observed in the general population.
Our results are consistent with the conclusions reported
by Illes and Chin, and with the recommendations pro-
vided by the Detection and Disclosure of Incidental Find-
ings in Neuroimaging Research workshop, which states
that there is no single correct approach to IFs, and more
than one morally acceptable option may exist depending
on the research environment or specialization of the PI
[2,14]. Milstein asserts that PIs may be legally required to
provide measures that meet the highest standards of
medical practice, regardless of differences in their research
environments or specializations compared to those of
medical doctors [13]. However, both investigators and the
general population in our study demanded more responsi-
bility from PIs with physician licenses at medical institu-
tions, although they were more lenient toward non-
licensed PIs at non-medical institutions. As the presentstudy did not provide any insight regarding the reason be-
hind this outcome, further research is warranted.
Recommendations for handling IFs according to the
SRPBS
Based on the relevant publications [7,31] and our pre-
liminary results, we submitted a recommendation [37]
to the SRPBS suggesting the following approach for ad-
dressing IFs.
With respect to all brain images taken during a
neuroscience research study conducted by the SRPBS,
it is desirable that a licensed physician performs a
screening test to appropriately examine if a clear
abnormality exists. For the time being, we will treat
every abnormality this way on a trial basis to help
shed light on unforeseen issues. Re-examination of this
method after a year is desirable [37].
Adopting option 1 or 2, in which no action is taken in
response to a finding, essentially denies the PI’s responsi-
bility to the participant. Even though a PI will not be
held liable as a physician would, such behavior may be
considered irresponsible, as the project is government
funded. There is a general consensus among the PIs in
our study (Figure 1) and the overseas research commu-
nity regarding PI responsibility in addressing IFs [6,7].
In option 3, in which a specialist is not involved, errors
associated with false negatives and false positives are ex-
pected to increase [31,37]. Furthermore, the general
population in our study considered specialist involve-
ment appropriate regardless of the PI’s specialization or
research environment (Figures 2 and 3, and Table 3).
The option without specialist involvement is unsuitable
for research institutions receiving public funds, given
that the majority of the general population desired a
more aggressive response in view of the potential harm
that can result from false-negative and false-positive
errors.
If reducing errors (i.e., false negatives and false posi-
tives) is our goal, then option 4 is also inadequate. Al-
though false-positive errors are likely to decrease if a
discovered finding is confirmed by a specialist, false-
negative errors would still remain high in this setting,
because the study is not performed by a specialist.
Therefore, options that potentially reduce both types of
errors (option 5 or higher) are more desirable. However,
option 6 comes exceedingly close to medical practice,
and may not only exacerbate “therapeutic misconcep-
tion” by participants but also go beyond expected funda-
mental responsibilities of PIs. Although a small
proportion of the general population selected option 6
(Figures 2 and 3) in our study, an option that exacer-
bates “therapeutic misconception” could distort risk-
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informed consent impossible [1,7,11,12,26,36].
For all brain images taken during the course of research
studies conducted as part of the SRPBS, we conclude that
image evaluation by a specialist is desirable (option 5). We
also recommend that investigators be thorough in obtain-
ing informed consent in an effort to discourage “therapeutic
misconception” and that the SRPBS provide economic
assistance to research facilities that may have difficulty
implementing this option. These recommendations were
adopted by the SRPBS and implemented on a trial basis in
April 2012. However, consistent with the investigators’
views in the present study (Figures 2 and 3), several studies
do not support option 5 [3,11,12,14,30,32,33]. For this rea-
son, future studies on investigator and participant attitudes
and IF detection rates are required to evaluate the success
of the implemented proposal. Investigation of the impact of
IF-addressing measures based on the present proposal, as
well as IF detection rates among all images in the SRPBS, is
currently underway.
Conclusions
It is important to note that our study had some sampling
limitations. First, study participants included a small num-
ber of PIs and investigators. Given that many of them
belonged to leading Japanese research facilities with rela-
tively abundant human and economic resources, other op-
tions may have been selected, if PIs and investigators from
outside the SRPBS were included. Moreover, not all investi-
gators conducted human research using MRI or fMRI.
However, our statistical analyses revealed that the type of
research or use of imaging equipment did not alter investi-
gator attitudes toward IFs handling procedures.
Second, the general population consisted of individuals
who volunteer to participate in studies conducted by a
research firm, and who decided to complete our ques-
tionnaire. Therefore, we cannot rule out the possibility
that the majority of these participants had an interest in
neuroimaging research and that they did not truly repre-
sent the general public regarding views on IF issues.
However, given the likelihood that our participants
responded to the questionnaire without fully under-
standing what an IF is, it is possible that their views are
similar to those held by potentially eligible research
participants.
The questionnaires used in this study did not address is-
sues of how or who should notify participants in the case
of a suspicious IF, despite the relative importance of these
issues. This could be considered another limitation. We
are currently investigating disclosure conditions at each
facility conducting an SRPBS project, as well as the impact
of disclosing findings on research participants.
We conducted two questionnaire surveys to clarify i)
how IFs are addressed at neuroimaging research facilitiesin Japan and ii) the views of investigators and the gen-
eral population regarding the handling of IFs. We found
that almost half of the PIs at facilities conducting human
research using MRI or fMRI had no or little knowledge
regarding the type of approach being employed to han-
dle IFs. Nevertheless, their responses indicated a willing-
ness to improve the current status, as long as sufficient
resources are provided. The general population tended
to support measures for handling IFs that go beyond
those supported by investigators. Both investigators and
the general population demanded more responsibility
from PIs with physician licenses at medical institutions,
although they were more lenient toward non-licensed
PIs at non-medical institutions.
This study is empirical in its approach and is not
intended to demonstrate clear norms. However, a large
portion of the preliminary results obtained from this
study was reflected in a proposal regarding approaches
to IFs, which was subsequently included in the guide-
lines for national research projects. In this regard, the
present study is of practical significance. We hope that
the results of this study will be used as a reference, not
only to help establish policies and guidelines in Japan
and other countries but also to contribute to the devel-
opment of neuroimaging research.
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